83 related articles for article (PubMed ID: 7593455)
1. Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus.
Thompson DB; Samowitz WS; Odelberg S; Davis RK; Szabo J; Heath H
J Clin Endocrinol Metab; 1995 Nov; 80(11):3377-80. PubMed ID: 7593455
[TBL] [Abstract][Full Text] [Related]
2. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.
Farnebo F; Enberg U; Grimelius L; Bäckdahl M; Schalling M; Larsson C; Farnebo LO
J Clin Endocrinol Metab; 1997 Oct; 82(10):3481-6. PubMed ID: 9329389
[TBL] [Abstract][Full Text] [Related]
4. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas.
Cetani F; Pinchera A; Pardi E; Cianferotti L; Vignali E; Picone A; Miccoli P; Viacava P; Marcocci C
J Bone Miner Res; 1999 Jun; 14(6):878-82. PubMed ID: 10352095
[TBL] [Abstract][Full Text] [Related]
5. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor.
Carling T; Szabo E; Bai M; Ridefelt P; Westin G; Gustavsson P; Trivedi S; Hellman P; Brown EM; Dahl N; Rastad J
J Clin Endocrinol Metab; 2000 May; 85(5):2042-7. PubMed ID: 10843194
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in parathyroid glands of familial hypercalcemia with hypercalciuria and point mutation in calcium receptor.
Szabo E; Carling T; Hessman O; Rastad J
J Clin Endocrinol Metab; 2002 Aug; 87(8):3961-5. PubMed ID: 12161540
[TBL] [Abstract][Full Text] [Related]
7. A possible tumor suppressor gene for parathyroid adenomas.
Iwasaki H
Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
9. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.
Heath H; Odelberg S; Jackson CE; Teh BT; Hayward N; Larsson C; Buist NR; Krapcho KJ; Hung BC; Capuano IV; Garrett JE; Leppert MF
J Clin Endocrinol Metab; 1996 Apr; 81(4):1312-7. PubMed ID: 8636323
[TBL] [Abstract][Full Text] [Related]
10. A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer.
Cetani F; Pardi E; Viacava P; Pollina GD; Fanelli G; Picone A; Borsari S; Gazzerro E; Miccoli P; Berti P; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2004 Jan; 60(1):99-106. PubMed ID: 14678295
[TBL] [Abstract][Full Text] [Related]
11. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.
Tahara H; Smith AP; Gas RD; Cryns VL; Arnold A
Cancer Res; 1996 Feb; 56(3):599-605. PubMed ID: 8564978
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors.
Hosokawa Y; Pollak MR; Brown EM; Arnold A
J Clin Endocrinol Metab; 1995 Nov; 80(11):3107-10. PubMed ID: 7593409
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.
Samander EH; Arnold A
J Clin Endocrinol Metab; 2006 Dec; 91(12):5019-21. PubMed ID: 17003089
[TBL] [Abstract][Full Text] [Related]
14. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
15. Clonal loss of one chromosome 11 in a parathyroid adenoma.
Arnold A; Kim HG
J Clin Endocrinol Metab; 1989 Sep; 69(3):496-9. PubMed ID: 2569472
[TBL] [Abstract][Full Text] [Related]
16. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
17. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11.
Falchetti A; Bale AE; Amorosi A; Bordi C; Cicchi P; Bandini S; Marx SJ; Brandi ML
J Clin Endocrinol Metab; 1993 Jan; 76(1):139-44. PubMed ID: 8421078
[TBL] [Abstract][Full Text] [Related]
18. Genetic and clinical characterization of sporadic cystic parathyroid tumours.
Villablanca A; Farnebo F; Teh BT; Farnebo LO; Höög A; Larsson C
Clin Endocrinol (Oxf); 2002 Feb; 56(2):261-9. PubMed ID: 11874419
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutation of the MEN1 gene in parathyroid tumours.
Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
